Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection

SILVIU GULER-MARGARITIS, ADRIANA MERCAN-STANCIU, LETITIA TOMA, DANIEL RUSIE, TEODORA ISAC, MIHAI DODOT, ANCA ZGURA, NICOLAE BACALBASA, BOGDAN HAINEALA, DUMITRU CRISTINEL BADIU, DRAGOS SERBAN and ELENA LAURA ILIESCU
In Vivo November 2021, 35 (6) 3377-3383; DOI: https://doi.org/10.21873/invivo.12636
SILVIU GULER-MARGARITIS
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
2Department of Urology, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ADRIANA MERCAN-STANCIU
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LETITIA TOMA
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIEL RUSIE
4Department of General Surgery, Clinical Emergency Hospital, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TEODORA ISAC
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIHAI DODOT
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANCA ZGURA
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
5Department of Oncology-Radiotherapy, “Prof Dr Alexandru Trestioreanu” Institute of Oncology, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NICOLAE BACALBASA
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BOGDAN HAINEALA
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
2Department of Urology, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DUMITRU CRISTINEL BADIU
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
6General Surgery Department, Bagdasar Arseni Clinical Emergency Hospital, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: doctorcristianbadiu{at}yahoo.com
DRAGOS SERBAN
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
7Department of Surgery, University Emergency Hospital, Bucharest, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELENA LAURA ILIESCU
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table I.
  • Table II.
  • Table III.
  • Table IV.
PreviousNext
Back to top

In this issue

In Vivo
Vol. 35, Issue 6
November-December 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection
SILVIU GULER-MARGARITIS, ADRIANA MERCAN-STANCIU, LETITIA TOMA, DANIEL RUSIE, TEODORA ISAC, MIHAI DODOT, ANCA ZGURA, NICOLAE BACALBASA, BOGDAN HAINEALA, DUMITRU CRISTINEL BADIU, DRAGOS SERBAN, ELENA LAURA ILIESCU
In Vivo Nov 2021, 35 (6) 3377-3383; DOI: 10.21873/invivo.12636

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection
SILVIU GULER-MARGARITIS, ADRIANA MERCAN-STANCIU, LETITIA TOMA, DANIEL RUSIE, TEODORA ISAC, MIHAI DODOT, ANCA ZGURA, NICOLAE BACALBASA, BOGDAN HAINEALA, DUMITRU CRISTINEL BADIU, DRAGOS SERBAN, ELENA LAURA ILIESCU
In Vivo Nov 2021, 35 (6) 3377-3383; DOI: 10.21873/invivo.12636
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Observational Study on the Effectiveness of L-Arginine Plus Vitamin C in the Management of Cancer-related Fatigue
  • Signal Detection Analysis of Hypnotic-induced Respiratory Depression
  • Development and Validation of an EHR-based Algorithm for Identifying Pneumocystis jirovecii Pneumonia
Show more Clinical Studies

Keywords

  • COVID-19
  • direct-acting antivirals
  • hepatocellular carcinoma
  • hepatitis C virus infection
  • SARS-CoV-2
In Vivo

© 2026 In Vivo

Powered by HighWire